GBX1
gene geneOn this page
Summary
GBX1 (gastrulation brain homeobox 1, HGNC:4185) is a protein-coding gene on chromosome 7q36.1, encoding Homeobox protein GBX-1 (Q14549).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of nervous system development and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within adult walking behavior; neuron differentiation; and proprioception. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 2636 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 58 total
- MANE Select transcript:
NM_001098834
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4185 |
| Approved symbol | GBX1 |
| Name | gastrulation brain homeobox 1 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000164900 |
| Ensembl biotype | protein_coding |
| OMIM | 603354 |
| Entrez | 2636 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000297537, ENST00000475831
RefSeq mRNA: 1 — MANE Select: NM_001098834
NM_001098834
CCDS: CCDS43682
Canonical transcript exons
ENST00000297537 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001088391 | 151148009 | 151149142 |
| ENSE00001527802 | 151167011 | 151167694 |
Expression profiles
Bgee: expression breadth broad, 57 present calls, max score 80.35.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0917 / max 9.7873, expressed in 35 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86876 | 0.0878 | 33 |
| 86877 | 0.0039 | 1 |
Top tissues by expression
195 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 80.35 | gold quality |
| secondary oocyte | CL:0000655 | 80.05 | gold quality |
| left testis | UBERON:0004533 | 79.26 | gold quality |
| testis | UBERON:0000473 | 76.32 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 75.31 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.23 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 74.95 | gold quality |
| sperm | CL:0000019 | 74.92 | gold quality |
| muscle of leg | UBERON:0001383 | 73.73 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.40 | gold quality |
| biceps brachii | UBERON:0001507 | 71.70 | gold quality |
| quadriceps femoris | UBERON:0001377 | 71.05 | gold quality |
| oocyte | CL:0000023 | 70.97 | silver quality |
| vastus lateralis | UBERON:0001379 | 70.48 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 70.37 | gold quality |
| muscle tissue | UBERON:0002385 | 69.00 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 68.66 | gold quality |
| superficial temporal artery | UBERON:0001614 | 67.81 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 67.61 | gold quality |
| endometrium epithelium | UBERON:0004811 | 66.09 | gold quality |
| heart right ventricle | UBERON:0002080 | 65.33 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 64.85 | gold quality |
| cerebellar vermis | UBERON:0004720 | 64.18 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 64.07 | gold quality |
| deltoid | UBERON:0001476 | 63.90 | gold quality |
| apex of heart | UBERON:0002098 | 63.85 | gold quality |
| cardiac ventricle | UBERON:0002082 | 63.82 | gold quality |
| heart left ventricle | UBERON:0002084 | 63.81 | gold quality |
| jejunal mucosa | UBERON:0000399 | 61.51 | gold quality |
| mammary duct | UBERON:0001765 | 61.50 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.63 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0889.1 | GBX1 | HOX |
| MA0889.2 | GBX1 | HOX |
JASPAR matrix evidence (PMIDs): PMID:18585359
Literature-anchored findings (GeneRIF, showing 2)
- Study reveals the preferential expression of GBX1 by germinal vesicle (GV) oocytes. (PMID:16597639)
- Dynamic local polymorphisms in the Gbx1 homeodomain induced by DNA binding have been reported. (PMID:27396829)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gbx1 | ENSDARG00000071418 |
| mus_musculus | Gbx1 | ENSMUSG00000067724 |
| rattus_norvegicus | Gbx1 | ENSRNOG00000013369 |
| drosophila_melanogaster | unpg | FBGN0015561 |
Paralogs (1): GBX2 (ENSG00000168505)
Protein
Protein identifiers
Homeobox protein GBX-1 — Q14549 (reviewed: Q14549)
Alternative names: Gastrulation and brain-specific homeobox protein 1
All UniProt accessions (1): Q14549
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001092304* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR020479 | HD_metazoa | Domain |
| IPR042982 | GBX-1/2 | Family |
Pfam: PF00046
UniProt features (13 total): compositionally biased region 4, helix 3, region of interest 2, chain 1, DNA-binding region 1, sequence variant 1, strand 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2M34 | SOLUTION NMR | |
| 2ME0 | SOLUTION NMR | |
| 2ME6 | SOLUTION NMR | |
| 2N8G | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14549-F1 | 60.75 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 63 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_BEHAVIOR, GOBP_ADULT_BEHAVIOR, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_ADULT_LOCOMOTORY_BEHAVIOR, GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD, GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION, GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT, GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION, GOBP_SENSORY_PERCEPTION, GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_NEURON_FATE_COMMITMENT, GOBP_NEUROMUSCULAR_PROCESS
GO Biological Process (8): regulation of transcription by RNA polymerase II (GO:0006357), adult walking behavior (GO:0007628), proprioception (GO:0019230), spinal cord motor neuron differentiation (GO:0021522), neuron fate commitment (GO:0048663), regulation of nervous system development (GO:0051960), sensory neuron axon guidance (GO:0097374), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| adult locomotory behavior | 1 |
| walking behavior | 1 |
| sensory perception | 1 |
| neuromuscular process controlling posture | 1 |
| cell differentiation in spinal cord | 1 |
| ventral spinal cord development | 1 |
| central nervous system neuron differentiation | 1 |
| neuron differentiation | 1 |
| cell fate commitment | 1 |
| nervous system development | 1 |
| regulation of multicellular organismal development | 1 |
| axon guidance | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
574 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GBX1 | LHX8 | Q68G74 | 897 |
| GBX1 | SOHLH1 | Q5JUK2 | 825 |
| GBX1 | DRC11L | A6NCM1 | 543 |
| GBX1 | LHX6 | Q9UPM6 | 472 |
| GBX1 | ZNF879 | B4DU55 | 392 |
| GBX1 | NPAS1 | Q99742 | 389 |
| GBX1 | ENTREP2 | O60320 | 384 |
| GBX1 | PAX2 | Q02962 | 366 |
| GBX1 | ZNF391 | Q9UJN7 | 358 |
| GBX1 | ISL1 | P20663 | 356 |
| GBX1 | C7orf33 | Q8WU49 | 348 |
| GBX1 | LHX5 | Q9H2C1 | 346 |
| GBX1 | Q05D86 | Q05D86 | 340 |
| GBX1 | EN2 | P19622 | 337 |
| GBX1 | RNF212 | Q495C1 | 335 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GBX1 | DNAJC6 | psi-mi:“MI:0914”(association) | 0.350 |
| GBX2 | FHL3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (8): PKMYT1 (Affinity Capture-MS), TRIM11 (Affinity Capture-MS), GBX1 (Affinity Capture-MS), GABPA (Affinity Capture-MS), DNAJC6 (Affinity Capture-MS), GRN (Affinity Capture-MS), QPRT (Affinity Capture-MS), NAALAD2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1W2PQ73, A1YF16, A1YG93, A2RU54, A5PKG8, O02786, O14813, O15353, O35602, O43638, O57601, P13297, P19419, P28360, P35548, P41969, P42580, P43687, P49640, P50223, P50548, P52946, P52950, P63156, P63157, P70459, P78413, Q03358, Q14549, Q2VL78, Q2VL79, Q2VL82, Q2VL83, Q2VL84, Q2VL85, Q2VL86, Q2VL87, Q2VL88, Q5NSW5, Q61575
Diamond homologs: A1YER7, A1YF08, A1YFD8, A1YFY3, A1YG85, A1YGA4, A2D4P8, A2D5I1, A2D5K9, A2D5Y4, A2T6X6, A2T756, A2T779, A2T7T2, F1Q4R9, M0R6D8, O13074, O42230, O42365, O42367, O42506, O57374, P06798, P07548, P09016, P09017, P09019, P09020, P09021, P09067, P09070, P09074, P0C1T1, P10178, P10284, P10628, P14652, P14837, P14838, P14840
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
303 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:151167004:CACTT:C | donor_loss | 0.9900 |
| 7:151167005:ACTTA:A | donor_loss | 0.9900 |
| 7:151167006:CTTAC:C | donor_loss | 0.9900 |
| 7:151167007:TTAC:T | donor_loss | 0.9900 |
| 7:151167008:TACCG:T | donor_loss | 0.9900 |
| 7:151167009:A:AC | donor_gain | 0.9900 |
| 7:151167009:A:AG | donor_loss | 0.9900 |
| 7:151167010:C:CC | donor_gain | 0.9900 |
| 7:151167010:CCGGG:C | donor_gain | 0.9900 |
| 7:151167010:CCGG:C | donor_gain | 0.9800 |
| 7:151149140:CTG:C | acceptor_gain | 0.9700 |
| 7:151149160:CCAA:C | acceptor_gain | 0.9700 |
| 7:151149161:CAA:C | acceptor_gain | 0.9700 |
| 7:151149162:A:T | acceptor_gain | 0.9700 |
| 7:151149163:A:AC | acceptor_gain | 0.9700 |
| 7:151149163:A:C | acceptor_gain | 0.9700 |
| 7:151149167:A:C | acceptor_gain | 0.9700 |
| 7:151149138:CTCTG:C | acceptor_gain | 0.9600 |
| 7:151149167:A:AC | acceptor_gain | 0.9600 |
| 7:151167009:AC:A | donor_gain | 0.9600 |
| 7:151167010:CC:C | donor_gain | 0.9600 |
| 7:151167010:CCG:C | donor_gain | 0.9600 |
| 7:151149143:C:CC | acceptor_gain | 0.9300 |
| 7:151149139:TCTG:T | acceptor_loss | 0.9200 |
| 7:151149142:GCTGT:G | acceptor_loss | 0.9200 |
| 7:151149143:CTGTG:C | acceptor_loss | 0.9200 |
| 7:151149144:T:G | acceptor_loss | 0.9200 |
| 7:151149154:A:T | acceptor_gain | 0.9200 |
| 7:151149141:TG:T | acceptor_gain | 0.9100 |
| 7:151149145:G:C | acceptor_gain | 0.9100 |
AlphaMissense
2307 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:151148659:A:C | I341R | 1.000 |
| 7:151148659:A:G | I341T | 1.000 |
| 7:151148659:A:T | I341K | 1.000 |
| 7:151148665:A:T | V339D | 1.000 |
| 7:151148668:A:T | V338D | 1.000 |
| 7:151148671:A:C | I337S | 1.000 |
| 7:151148728:C:G | R318P | 1.000 |
| 7:151148729:G:A | R318C | 1.000 |
| 7:151148729:G:T | R318S | 1.000 |
| 7:151148730:C:A | K317N | 1.000 |
| 7:151148730:C:G | K317N | 1.000 |
| 7:151148732:T:C | K317E | 1.000 |
| 7:151148733:C:A | W316C | 1.000 |
| 7:151148733:C:G | W316C | 1.000 |
| 7:151148735:A:G | W316R | 1.000 |
| 7:151148735:A:T | W316R | 1.000 |
| 7:151148736:C:A | K315N | 1.000 |
| 7:151148736:C:G | K315N | 1.000 |
| 7:151148737:T:A | K315M | 1.000 |
| 7:151148738:T:C | K315E | 1.000 |
| 7:151148738:T:G | K315Q | 1.000 |
| 7:151148740:G:T | A314D | 1.000 |
| 7:151148741:C:G | A314P | 1.000 |
| 7:151148743:C:G | R313P | 1.000 |
| 7:151148744:G:A | R313W | 1.000 |
| 7:151148744:G:C | R313G | 1.000 |
| 7:151148746:C:A | R312L | 1.000 |
| 7:151148746:C:G | R312P | 1.000 |
| 7:151148747:G:C | R312G | 1.000 |
| 7:151148748:A:C | N311K | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000016666 (7:151147577 G>A,T), RS1000084655 (7:151149211 T>C,G), RS1000138844 (7:151157122 C>G), RS1000418276 (7:151160909 G>T), RS1000447064 (7:151162224 C>T), RS1000614080 (7:151166117 A>G), RS1000696647 (7:151155374 T>C), RS1000705895 (7:151149489 C>G,T), RS1000747435 (7:151155736 T>G), RS1000756906 (7:151149127 T>C), RS1001159869 (7:151159251 A>C), RS1001182716 (7:151161241 G>A), RS1001304788 (7:151154207 G>A), RS1001399654 (7:151168256 C>A,T), RS1001454093 (7:151160589 T>C)
Disease associations
OMIM: gene MIM:603354 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003476_9 | Eyebrow thickness | 7.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| bisphenol A | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, decreases reaction | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Lipopolysaccharides | increases expression, decreases reaction | 1 |
| Triclosan | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.